Cardiovascular health technology assessment: recommendations to improve the quality of evidence

The aim of this article is to review the role of Health Technology Assessment (HTA) organisations in appraising and recommending innovative cardiovascular technologies. We consider how bias impairs the quality of evidence from clinical trials involving cardiovascular healthcare technologies. Finally...

Descripción completa

Detalles Bibliográficos
Autores principales: Berry, Colin, Corcoran, David, Mangion, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Health Care Delivery, Economics and Global Health Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443128/
https://www.ncbi.nlm.nih.gov/pubmed/30997126
http://dx.doi.org/10.1136/openhrt-2018-000930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443128/
https://www.ncbi.nlm.nih.gov/pubmed/30997126
http://dx.doi.org/10.1136/openhrt-2018-000930

Ejemplares similares